Comparative Analysis of Short-Course Vs Long Course Antibiotic Therapy among Patients with Complicated Intra-Abdominal Infections
Reads0
Chats0
TLDR
It can be concluded that the short course antibiotic therapy has good efficacy to treat CIAI when the primary foci of infection are surgically extracted with adequate source control.Abstract:
Background: Complicated intra-abdominal infections have become a major health challenge that merits safe and efficacious therapy. Antibiotic therapy is the treatment of choice, however the duration of antibiotic use is debatable.
Objective: To compare the safety and efficacy of the short course and long course antibiotic therapy towards the treatment and the progressive outcome of patients presented with complicated intra-abdominal infections.
Methodology: This comparative study was carried out on 94 subjects (chosen via non-probability, consecutive sampling), who presented with complicated intra-abdominal infections, had signs and symptoms of infection along with ultrasound abdomen examination consistent with infective foci and routine blood test showing raised total leukocyte count, at the Department of Surgery - Liaquat University Hospital, Hyderabad. Subjects were divided into two groups (47 in each) through a random assignments. Group-A was kept on a short course (5-7-days) while Group-B was kept on a long course (7-10 days) antibiotic therapy. Data were documented using a structured questionnaire, including inquiries related to sociodemographic details, disease specifics, and observed for the outcome variables (mainly postoperative early resolution of infection and long hospital stay).
Results: In Group A, resolution of infection was achieved in 59.57%, 29.79% and 10.64% patients on day 5, 6 and 7, espectively. In Group B, esoluation of infection was only reported as 42.55%, 36.17% and 21.28% on day 5, 6 and 7, respectively. The median duration of taking antibiotic was almost half in short course group than the long. Surgical site infections were commonly observed in Group B patients. There was no mortality observed in both groups. There is no significance difference observed in primary outcome of clinical cure among the groups.
Conclusion: It can be concluded that the short course antibiotic therapy has good efficacy to treat CIAI when the primary foci of infection are surgically extracted with adequate source control.read more
References
More filters
Journal ArticleDOI
Impact of antimicrobial therapy on the gut microbiome.
TL;DR: The impact of the antimicrobials often used for the treatment of sepsis on the gut microbiota is discussed to help develop future therapies to circumvent damage to, or restore, the microbiome.
Journal ArticleDOI
Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial.
Philippe Montravers,Florence Tubach,Thomas Lescot,Benoit Veber,Marina Esposito-Farèse,Philippe Seguin,Catherine Paugam,Alain Lepape,Claude Meistelman,Joel Cousson,Antoine Tesniere,Gaëtan Plantefève,Gilles Blasco,Karim Asehnoune,Samir Jaber,Sigismond Lasocki,Hervé Dupont +16 more
TL;DR: Short-course antibiotic therapy in critically ill ICU patients with PIAI reduces antibiotic exposure, and Continuation of treatment until day 15 is not associated with any clinical benefit.
Journal ArticleDOI
Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levels.
Isaiah R. Turnbull,Pardis Javadi,Timothy G. Buchman,Richard S. Hotchkiss,Irene E. Karl,Craig M. Coopersmith +5 more
TL;DR: There is a threshold IL-6 level that can be identified 6 h after sepsis above which animals are destined to die, and antibiotic treatment does not alter their outcome, indicating that antibiotics improve outcome in murine sepsi, regardless of injury severity.
Journal ArticleDOI
Plasma bacterial and mitochondrial DNA distinguish bacterial sepsis from sterile systemic inflammatory response syndrome and quantify inflammatory tissue injury in nonhuman primates.
Tolga Sursal,Deborah J. Stearns-Kurosawa,Kiyoshi Itagaki,Sun-Young Oh,Shiqin Sun,Shinichiro Kurosawa,Carl J. Hauser +6 more
TL;DR: Mitochondrial DNA and bDNA polymerase chain reactions can quantify tissue injury incurred by septic or sterile mechanisms and suggest the source of SIRS of unknown origin.
Journal ArticleDOI
A Prospective, Double-Blind, Multicenter, Randomized Trial Comparing Ertapenem 3 Vs ≥5 Days in Community-Acquired Intraabdominal Infection
Antonio Basoli,Piero Chirletti,Ercole Cirino,Nicola G. D’Ovidio,Giovanni Battista Doglietto,Domenico Giglio,Stefano Maria Giulini,Alberto Malizia,Mario Taffurelli,Jelena Petrovic,Maurizio Ecari +10 more
TL;DR: It is demonstrated that, in patients with localized community-acquired intraabdominal infection, a 3-day course of ertapenem had the same clinical and bacteriological efficacy as a standard duration.